• Discussion on the POINT trial (with Marc Fisher and Greg Albers)

  • Mar 2 2021
  • Length: 18 mins
  • Podcast

Discussion on the POINT trial (with Marc Fisher and Greg Albers)

Listen for free

View show details

  • Summary

  • Professor Marc Fisher and Dr Greg Albers discuss the POINT trial, also commenting on when to consider ticagrelor versus clopidogrel.

    This programme is made possible thanks to an independent educational grant from AstraZeneca.

    Find more information at https://ime.springerhealthcare.com/programs/emerging-dual-anti-platelet-therapy-strategies-for-neurologists-in-secondary-stroke-prevention/
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Discussion on the POINT trial (with Marc Fisher and Greg Albers)

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available